{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:21:32Z","timestamp":1788780092483,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068632"],"award-info":[{"award-number":["UM1AI068632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068616"],"award-info":[{"award-number":["UM1AI068616"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI106716"],"award-info":[{"award-number":["UM1AI106716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN275201800001I"],"award-info":[{"award-number":["HHSN275201800001I"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI110527"],"award-info":[{"award-number":["AI110527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI077505"],"award-info":[{"award-number":["AI077505"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI069465"],"award-info":[{"award-number":["UM1AI069465"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD081929"],"award-info":[{"award-number":["R01HD081929"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pregnancy is accompanied by immune suppression. We hypothesized that Mycobacterium tuberculosis-specific inflammatory responses used to identify latent tuberculosis infection (LTBI) lose positivity during pregnancy. We also hypothesized that isoniazid preventive therapy (IPT) may revert LTBI diagnoses because of its sterilizing activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>944 women with human immunodeficiency virus infection (HIV) participating in a randomized, double-blind, placebo-controlled study comparing 28 weeks of IPT antepartum versus postpartum, were tested by QuantiFERON-gold-in-tube (QGIT) antepartum and by QGIT and tuberculin skin test (TST) at delivery and postpartum. Serial QGIT positivity was assessed by logistic regression using generalized estimating equations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From entry to delivery, 68 (24%) of 284 QGIT-positive women reverted to QGIT-negative or indeterminate. Of these, 42 (62%) recovered QGIT positivity postpartum. The loss of QGIT positivity during pregnancy was explained by decreased interferon gamma (IFN\u03b3) production in response to TB antigen and\/or mitogen. At delivery, LTBI was identified by QGIT in 205 women and by TST in 113 women. Corresponding numbers postpartum were 229 and 122 women. QGIT and TST kappa agreement coefficients were 0.4 and 0.5, respectively. Among QGIT-positive women antepartum or at delivery, 34 (12%) reverted to QGIT-negative after IPT. There were no differences between women who initiated IPT antepartum or postpartum.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Decreased IFN\u03b3 responses in pregnancy reduced QGIT positivity, suggesting that this test cannot reliably rule out LTBI during pregnancy. TST was less affected by pregnancy, but had lower positivity compared to QGIT at all time points. IPT was associated with loss of QGIT positivity, the potential clinical consequences of which need to be investigated.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciaa1083","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T19:13:19Z","timestamp":1595617999000},"page":"e3555-e3562","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Pregnancy and Isoniazid Preventive Therapy on<i>Mycobacterium tuberculosis<\/i>Interferon Gamma Response Assays in Women With HIV"],"prefix":"10.1093","volume":"73","author":[{"given":"Adriana","family":"Weinberg","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Medicine and Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Aaron","sequence":"additional","affiliation":[{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Montepiedra","sequence":"additional","affiliation":[{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Sterling","sequence":"additional","affiliation":[{"name":"Vanderbilt Tuberculosis Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Browning","sequence":"additional","affiliation":[{"name":"Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandina","family":"Mmbaga","sequence":"additional","affiliation":[{"name":"Kilimanjaro Christian Medical Centre (KCMC) Moshi, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tichaona","family":"Vhembo","sequence":"additional","affiliation":[{"name":"University of Zimbabwe College of Health Sciences Clinical Trials Research Centre (UZCHS-CTRC), Harare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, BJGMC, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enid","family":"Kabugho","sequence":"additional","affiliation":[{"name":"Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaerolwe","family":"Masheto","sequence":"additional","affiliation":[{"name":"Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana, and Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Pahwa","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti S","family":"Mathad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia M","family":"LaCourse","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"McCarthy","sequence":"additional","affiliation":[{"name":"FHI 360, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bradford","sequence":"additional","affiliation":[{"name":"FHI 360, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Theron","sequence":"additional","affiliation":[{"name":"FAM-CRU CRS, Department of Obstetrics and Gynaecology, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Costello","sequence":"additional","affiliation":[{"name":"University of California Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Frontier Science Foundation, Amherst, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie F","family":"Pierre","sequence":"additional","affiliation":[{"name":"Les Centres GHESKIO, Port-au-Prince, Ha\u00efti"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamunkhwala","family":"Gausi","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Haas","sequence":"additional","affiliation":[{"name":"Vanderbilt Tuberculosis Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Gupta","sequence":"additional","affiliation":[{"name":"Departments of Medicine and International Health, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IMPAACT P1078 study team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandisa","family":"Nyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebogo J","family":"Kakhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsungai","family":"Chipato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Stranix-Chibanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishi","family":"Suryavanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuanglada","family":"Tongprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"de Vaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"2021110300070150000_CIT0001","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/cid\/cis732","article-title":"Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps","volume":"55","author":"Mathad","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021110300070150000_CIT0002","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1813060","article-title":"Isoniazid preventive therapy in HIV-infected pregnant and postpartum women","volume":"381","author":"Gupta","year":"2019","journal-title":"N Engl J Med"},{"key":"2021110300070150000_CIT0003","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2021110300070150000_CIT0004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"2021110300070150000_CIT0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"2021110300070150000_CIT0006","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"key":"2021110300070150000_CIT0007","doi-asserted-by":"crossref","first-page":"e0193589","DOI":"10.1371\/journal.pone.0193589","article-title":"Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting","volume":"13","author":"K\u00f6nig Walles","year":"2018","journal-title":"PLoS One"},{"key":"2021110300070150000_CIT0008","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","article-title":"Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country","volume":"22","author":"Stephan","year":"2008","journal-title":"AIDS"},{"key":"2021110300070150000_CIT0009","doi-asserted-by":"crossref","first-page":"e116268","DOI":"10.1371\/journal.pone.0116268","article-title":"Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting","volume":"9","author":"Buchwald","year":"2014","journal-title":"PLoS One"},{"key":"2021110300070150000_CIT0010","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2021110300070150000_CIT0011","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","article-title":"Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection","volume":"175","author":"Rangaka","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110300070150000_CIT0012","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2021110300070150000_CIT0013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"key":"2021110300070150000_CIT0014","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/cid\/civ155","article-title":"Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study","volume":"60","author":"Luetkemeyer","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021110300070150000_CIT0015","first-page":"128","article-title":"Effect of pregnancy on interferon gamma release assay and tuberculin skin test detection of latent TB infection among HIV-infected women in a high burden setting","author":"LaCourse","year":"2017"},{"key":"2021110300070150000_CIT0016","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201508-1595OC","article-title":"Quantitative IFN-\u03b3 and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women","volume":"193","author":"Mathad","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110300070150000_CIT0017","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/rccm.201106-1083OC","article-title":"Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study","volume":"185","author":"Zenner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110300070150000_CIT0018","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"2021110300070150000_CIT0019","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2021110300070150000_CIT0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3389\/fimmu.2018.01293","article-title":"Progesterone modulation of pregnancy-related immune responses","volume":"9","author":"Shah","year":"2018","journal-title":"Front Immunol"},{"key":"2021110300070150000_CIT0021","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/656332","article-title":"Interferon \u03b3 responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis","volume":"202","author":"Lahey","year":"2010","journal-title":"J Infect Dis"},{"key":"2021110300070150000_CIT0022","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021110300070150000_CIT0023","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4049\/jimmunol.1501996","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses","volume":"197","author":"Suliman","year":"2016","journal-title":"J Immunol"},{"key":"2021110300070150000_CIT0024","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-\u03b3-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"2021110300070150000_CIT0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing","volume":"180","author":"van Zyl-Smit","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110300070150000_CIT0026","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1183\/09031936.00117506","article-title":"Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay","volume":"29","author":"Leyten","year":"2007","journal-title":"Eur Respir J"},{"key":"2021110300070150000_CIT0027","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1183\/09031936.00014508","article-title":"Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts","volume":"32","author":"Richeldi","year":"2008","journal-title":"Eur Respir J"},{"key":"2021110300070150000_CIT0028","doi-asserted-by":"crossref","first-page":"e96613","DOI":"10.1371\/journal.pone.0096613","article-title":"Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection","volume":"9","author":"Johnson","year":"2014","journal-title":"PLoS One"},{"key":"2021110300070150000_CIT0029","doi-asserted-by":"crossref","first-page":"e36046","DOI":"10.1371\/journal.pone.0036046","article-title":"Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis","volume":"7","author":"Adekambi","year":"2012","journal-title":"PLoS One"},{"key":"2021110300070150000_CIT0030","doi-asserted-by":"crossref","first-page":"e97366","DOI":"10.1371\/journal.pone.0097366","article-title":"Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants","volume":"9","author":"O\u2019Shea","year":"2014","journal-title":"PLoS One"},{"key":"2021110300070150000_CIT0031","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2334-10-138","article-title":"Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children","volume":"10","author":"Connell","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2021110300070150000_CIT0032","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1513\/AnnalsATS.201310-378OC","article-title":"IFN-\u03b3 release assay conversions and reversions. Challenges with serial testing in U.S. health care workers","volume":"11","author":"Joshi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2021110300070150000_CIT0033","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-\u03b3 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110300070150000_CIT0034","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"Walzl","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2021110300070150000_CIT0035","doi-asserted-by":"crossref","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","article-title":"Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response","volume":"204 Suppl 4","author":"Achkar","year":"2011","journal-title":"J Infect Dis"},{"key":"2021110300070150000_CIT0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00005-009-0062-5","article-title":"Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease","volume":"58","author":"Cardona","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2021110300070150000_CIT0037","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/nm.4161","article-title":"Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography","volume":"22","author":"Esmail","year":"2016","journal-title":"Nat Med"},{"key":"2021110300070150000_CIT0038","author":"Gausi"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1083\/35226363\/ciaa1083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/9\/e3555\/41058762\/ciaa1083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/9\/e3555\/41058762\/ciaa1083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T11:08:39Z","timestamp":1667560119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/9\/e3555\/5877271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,7,28]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1083","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2020,7,28]]}}}